A Meta-analysis of Randomized Control Trials of Surgical Methods with Osteosarcoma Outcomes

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2017 Jan 15

PMID 28086937

Citations 42

Authors

Xiaojun He

Zhenzhen Gao

Hongwei Xu

Zhongwei Zhang

Peng Fu

Affiliations

Soon will be listed here.

Abstract

Background: Osteosarcoma is a high malignant neoplasm, and conflicting findings have been reported on the survival and function recovery of osteosarcoma patients experiencing limb salvage or amputation. In the present study, we compared limb salvage surgery (LSS) with amputation in clinical outcomes of osteosarcoma patients by a meta-analysis.

Methods: The survival rate of osteosarcoma patients was collected from research reports from CNKI, MEDLINE, EMBASE, the Cochrane Database, and Google Scholar till April 30, 2016. The quality of including articles was evaluated by two independent reviewers. Differences between patients undergoing limb salvage surgery and amputation were analyzed based on postoperative survival rates.

Results: Ten articles were included according to selection criteria. There were 1343 patients in total from these studies. Our results showed that there was no significant difference between limb salvage surgery and amputation according to local recurrence; however, patients with limb salvage surgery had a higher 5-year overall survival.

Conclusions: LSS results in higher 5-year survival rates and better survival, while not increasing the risk of local recurrence. This study provided more evidences to support limb salvage surgery as a considerable treatment of osteosarcoma patients.

Citing Articles

Limb Salvage Surgery in Pediatric Patients with Osteosarcoma.

Niculescu S, Grecu A, Gheonea C, Grecu D Curr Health Sci J. 2024; 50(3):360-367.

PMID: 39574503 PMC: 11580753. DOI: 10.12865/CHSJ.50.03.03.

Comparing quality of life in lower extremity tumor patients undergoing limb salvage surgery and amputation: a meta-analysis.

Banskota N, Lei S, Yuan D, Fang X, Banskota S, Zhang W Front Oncol. 2024; 13:1201202.

PMID: 38234404 PMC: 10792662. DOI: 10.3389/fonc.2023.1201202.

Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study.

Karda I, Wan Ismail W, Kamal A Sci Rep. 2023; 13(1):18541.

PMID: 37899365 PMC: 10613611. DOI: 10.1038/s41598-023-45808-7.

A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma.

Chen P, Shen J Bioengineering (Basel). 2023; 10(10).

PMID: 37892851 PMC: 10603950. DOI: 10.3390/bioengineering10101121.

Comparative study of gait parameters of patients undergoing distal femoral resections with non-operated and healthy limbs: a meta-analysis study.

Banskota N, Fang X, Yuan D, Zhang W, Duan H Front Oncol. 2023; 13:1089609.

PMID: 37810986 PMC: 10552754. DOI: 10.3389/fonc.2023.1089609.

References

Aksnes L, Bauer H, Jebsen N, Folleras G, Allert C, Haugen G . Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br. 2008; 90(6):786-94. DOI: 10.1302/0301-620X.90B6.19805. View

Meyers P, Schwartz C, Krailo M, Kleinerman E, Betcher D, Bernstein M . Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005; 23(9):2004-11. DOI: 10.1200/JCO.2005.06.031. View

Niu X, Ding Y . [The surgical treatment and outcome of nonmetastatic osteosarcoma of the extremity with pathologic fractures]. Zhonghua Wai Ke Za Zhi. 2008; 46(22):1730-3. View

JOHANSEN R, Nielsen O, Keller J . Functional outcome in sarcomas treated with limb-salvage surgery or amputation. Sarcoma. 2008; 2(1):19-23. PMC: 2395377. DOI: 10.1080/13577149878118. View

Bruns J, Luessenhop S, Behrens P . Cost analysis of three different surgical procedures for treatment of a pelvic tumour. Langenbecks Arch Surg. 1998; 383(5):359-63. DOI: 10.1007/s004230050149. View

Bacci G, Ferrari S, Donati D, Longhi A, Bertoni F, Di Fiore M . Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep. 1998; 5(5):1259-63. DOI: 10.3892/or.5.5.1259. View

Yin K, Liao Q, Zhong D, Ding J, Niu B, Long Q . Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med. 2012; 4(5):889-894. PMC: 3493816. DOI: 10.3892/etm.2012.685. View

Papagelopoulos P, Mavrogenis A, Savvidou O, Benetos I, Galanis E, Soucacos P . Pathological fractures in primary bone sarcomas. Injury. 2007; 39(4):395-403. DOI: 10.1016/j.injury.2007.07.018. View

Han G, Bi W, Xu M, Jia J, Wang Y . Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis. World J Surg. 2016; 40(8):2016-27. DOI: 10.1007/s00268-016-3500-7. View

10.

Fuchs N, Bielack S, Epler D, Bieling P, Delling G, Korholz D . Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998; 9(8):893-9. DOI: 10.1023/a:1008391103132. View

11.

Ekert H, Tiedemann K, Waters K, Ellis W . Experience with high dose multiagent chemotherapy and autologous bone marrow rescue in the treatment of twenty-two children with advanced tumours. Aust Paediatr J. 1984; 20(3):195-201. DOI: 10.1111/j.1440-1754.1984.tb00077.x. View

12.

Gaston C, Nakamura T, Reddy K, Abudu A, Carter S, Jeys L . Is limb salvage surgery safe for bone sarcomas identified after a previous surgical procedure?. Bone Joint J. 2014; 96-B(5):665-72. DOI: 10.1302/0301-620X.96B5.33140. View

13.

Hudson M, Jaffe M, Jaffe N, Ayala A, Raymond A, Carrasco H . Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol. 1990; 8(12):1988-97. DOI: 10.1200/JCO.1990.8.12.1988. View

14.

Rodan S, Imai Y, Thiede M, Wesolowski G, Thompson D, Bar-Shavit Z . Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res. 1987; 47(18):4961-6. View

15.

Carty C, Dickinson I, Watts M, Crawford R, Steadman P . Impairment and disability following limb salvage procedures for bone sarcoma. Knee. 2009; 16(5):405-8. DOI: 10.1016/j.knee.2009.02.006. View

16.

Ferguson P, McLaughlin C, Griffin A, Bell R, Deheshi B, Wunder J . Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol. 2010; 102(2):120-4. DOI: 10.1002/jso.21542. View

17.

Samardziski M, Zafiroski G, Tolevska C, Zafirova-Ivanovska B, Kostadinova-Kunovska S, Kalicanin-Markovska M . Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery). Prilozi. 2009; 29(2):309-23. View

18.

Mei J, Zhu X, Wang Z, Cai X . Functional outcomes and quality of life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2014; 134(11):1507-16. DOI: 10.1007/s00402-014-2086-5. View

19.

Simon M, Aschliman M, Thomas N, Mankin H . Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. 1986. J Bone Joint Surg Am. 2005; 87(12):2822. DOI: 10.2106/JBJS.8712.cl. View

20.

Winkler K, Beron G, Kotz R, SALZER-KUNTSCHIK M, Beck J, Beck W . Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study. J Cancer Res Clin Oncol. 1983; 106 Suppl:1-7. DOI: 10.1007/BF00625042. View